Health funding

Neion Bio is a biotechnology company focused on revolutionizing the production of biologic medicines using advanced genetic engineering techniques. The company targets the pharmaceutical industry, providing innovative solutions for biologics manufacturing through its unique platform that utilizes chicken eggs as production vessels. This funding round will help expand its pipeline and enhance its manufacturing capabilities.

MACC is a company focused on developing care homes. They are acquiring a site in Birmingham to build a 71-bed care home, which highlights their commitment to expanding healthcare facilities in the region.

OurMind is a startup focused on reducing the administrative burden in healthcare through artificial intelligence. By streamlining processes, they aim to improve efficiency for healthcare providers. The recent funding will help them enhance their AI solutions and expand their market reach.

Dentroid is a Canberra-based medtech startup that has developed needle-free dental technology aimed at providing pain relief during dental procedures without traditional local anaesthetic injections. The company has raised $32 million to commercialize its flagship Nuralyte technology through a global partnership with French dental products manufacturer Septodont.

4baseCare is a precision oncology startup that develops genomics-driven cancer diagnostics and AI-powered clinical decision support tools. The company aims to make precision oncology more inclusive for under-represented populations by decentralizing genomic testing infrastructure and expanding its services globally. With a focus on addressing gaps in population-relevant genomic data, 4baseCare is working to enable more personalized cancer treatment.

The microbubble startup is focused on developing innovative gene therapy solutions. With a significant funding round of $125 million, the company aims to launch a clinical trial next year, marking a pivotal step in its growth and development.

Parabilis Medicines is a biotechnology startup focused on developing therapies for 'undruggable' targets, particularly in cancer treatment. The company has raised significant funding to advance its innovative peptide drugs, known as 'Helicons', which aim to target difficult-to-reach cancer-driving proteins. Their most advanced candidate, zolucatetide, is set to enter Phase 3 trials for desmoid tumors in 2027.

Uncovr is a surgical AI startup that aims to transform surgical documentation using artificial intelligence. The company focuses on improving how healthcare providers analyze, document, code, and learn from surgical procedures, addressing significant discrepancies in data utilization within operating rooms.

01Health is a London-based healthcare company that aims to provide specialist care services traditionally found in Harley Street to a broader audience on the high street. This funding round will help them expand their reach and improve accessibility to quality healthcare services.

Hoola Health is a Bengaluru-based paediatric healthcare startup that operates child-focused healthcare clinics. It provides a wide range of services including consultations, vaccinations, and developmental therapies, combining physical healthcare with digital tools to help parents manage their child's health.

GT Medical Technologies develops innovative treatments for brain tumor patients, focusing on improving survival outcomes and quality of life. Their flagship product, GammaTile therapy, delivers immediate targeted radiation at the tumor site during surgery, aiming to reduce tumor regrowth and limit exposure to healthy brain tissue.

City Therapeutics is a biotechnology company focused on developing RNA interference (RNAi) therapies. Their innovative platform utilizes engineered RNAi trigger molecules to deliver treatments beyond the liver, targeting diseases such as thromboembolic disorders and Stargardt disease. The recent $99.5 million funding will support the advancement of their clinical pipeline.

Oak Hill Bio is a therapeutics company focused on developing treatments for rare diseases. They have secured funding to advance rugonersen, an experimental treatment for Angelman syndrome, into late-stage clinical testing, highlighting their commitment to addressing unmet medical needs in this community.

Kanvas Biosciences is focused on developing microbiome-based cancer therapies, leveraging a breakthrough imaging platform to map the gut microbiome. The company aims to improve cancer immunotherapy outcomes and address malnutrition-related gut diseases, with its foundational technology emerging from research at Cornell University.

Ilant Health is a New York-based company focused on obesity and cardiometabolic health. It provides a comprehensive care model that combines medical treatment, behavioral therapy, nutrition guidance, and physical activity support, utilizing AI to personalize care for individuals. The recent $15 million funding round highlights the growing demand for personalized obesity care solutions.

Wholeleaf is a Gurugram-based startup focused on developing natural pain therapeutics for chronic and neuropathic pain management. The company aims to expand its offline retail presence and enhance product development, currently leading the cannabinoid pain therapeutics category in India.

Stepful is a company focused on providing AI-powered medical training solutions. It aims to enhance the workforce pipeline in the healthcare sector by equipping individuals with the necessary skills and knowledge. The recent funding will help scale its operations and reach more aspiring healthcare professionals.

Immuneel Therapeutics is a cancer-focused biotech startup that develops cell and gene therapies designed to treat complex cancers. The company aims to make advanced immunotherapy treatments more accessible to patients in India and other emerging markets, with a focus on scaling manufacturing and advancing research.

Nul is a healthtech startup that offers a digital platform designed to help individuals reduce alcohol consumption through clinical care, prescription medication, and behavioral support. The company targets users seeking to manage their relationship with alcohol without traditional rehabilitation pathways, utilizing a subscription-based telehealth model. This funding will support its expansion across the UK and into the US market.

Imunon is a biotechnology company focused on developing innovative therapies for cancer treatment. The company is currently conducting a trial for ovarian cancer, which is a significant area of need in oncology. This funding will support their efforts to advance their clinical programs.

Joyvié Health is a company focused on rethinking continence underwear. Founded after a personal loss, it aims to provide innovative solutions for individuals dealing with incontinence. The recent funding will help them enhance their product offerings and reach a wider audience.

Novellia is a healthtech startup that has developed a Patient-Powered Data Platform, allowing individuals to securely access and organize their medical records from various healthcare providers. The platform aims to enhance medical research by providing deidentified and anonymized health data, with a focus on voluntary patient participation.

CrossBridge Bio is a Houston-based biotech startup that develops antibody-drug conjugates (ADCs) for cancer treatment. Founded in 2023, the company is notable for its innovative approach to combining targeted therapy with chemotherapy, aiming to kill cancer cells while preserving healthy tissue.

Apogee Therapeutics, Inc. is focused on developing innovative therapies for atopic dermatitis and other conditions. The company is expanding its clinical trials into asthma and eosinophilic esophagitis (EoE), supported by a significant funding deal with Blackstone.

NewLimit is a longevity biotech startup focused on reversing cellular aging through epigenetic reprogramming. The company aims to develop drugs that reset gene expression in aged cells, with plans to start human clinical trials in 2027 targeting alcohol-related liver disease. This funding round has significantly increased its valuation, reflecting strong investor confidence in its innovative approach.

Curebound is a community-powered cancer research accelerator dedicated to advancing breakthrough science into cures. It focuses on funding high-impact cancer studies and fostering collaborations among scientists, advocates, and philanthropists to improve cancer prevention, detection, and treatment.

Signos is a health technology company that focuses on using continuous glucose monitoring (CGM) technology to help individuals manage their weight. The company aims to expand the application of CGM beyond diabetes, targeting consumers interested in weight loss solutions. This funding round will support their efforts to broaden the use of CGM technology in the weight management market.

The Dublin startup is developing a wearable device designed to monitor and manage concussions. This innovative technology aims to enhance safety in sports and other activities where head injuries are a concern. The company is currently seeking €2.5 million in funding to further its development.

A Japanese biotech company is developing a drug aimed at regrowing teeth. This innovative approach targets dental health and aims to provide a solution for tooth loss.

LetsGetChecked is a health technology company that provides at-home health testing services. It targets consumers looking for convenient and private health testing solutions, making it easier for individuals to manage their health from home. The company raised €150 million, which is a significant amount in the health tech sector.

H1 is a healthcare data platform that provides detailed information about doctors to pharmaceutical companies, hospital systems, and health insurers. The company has recently secured a $40 million investment from CVS Health Ventures, highlighting its strong financial fundamentals and growth potential in a challenging investment environment.

Rosarium Health is a Houston-based startup that provides a home-based healthcare platform designed to coordinate home accessibility upgrades and modifications for seniors and people living with disabilities. The company has built a national network of over 800 clinicians and 3,000 contractors to streamline the delivery of these services, addressing the fragmented logistics often associated with home healthcare.

Garner Health is a company focused on improving healthcare by providing a ranking of the best doctors. This funding round will help them expand their services and reach more patients seeking quality healthcare.

YolTech is a gene editing startup focused on advancing CRISPR therapies. The company aims to develop innovative treatments in the field of genetic medicine and is preparing for a public offering in Hong Kong.

Solstice is an AI-native pharma marketing startup that aims to streamline the marketing and regulatory review processes for pharmaceutical companies. By leveraging AI technology, it significantly reduces the time required for campaign approvals, allowing companies to launch marketing campaigns in as little as 10 days. The startup has already partnered with several top pharmaceutical brands to enhance their marketing efficiency.

Secretome Therapeutics is focused on developing regenerative cardiac therapies, particularly targeting conditions like Duchenne muscular dystrophy associated cardiomyopathy. The company aims to restore and regenerate cardiac function through innovative cellular therapies, with recent funding set to advance their clinical trials and manufacturing capabilities.

Triomics is a company focused on streamlining cancer care through the use of artificial intelligence. Their innovative approach aims to improve patient outcomes and enhance the efficiency of cancer treatment processes. The recent funding will help them further develop their technology and expand their reach in the healthcare market.

Protuoso is a California-based biotech startup developing multifunctional biologics using a platform called MUXBODIES. The company aims to create therapies that target multiple disease pathways simultaneously, addressing limitations of traditional single-pathway drugs.

Ember LifeSciences is a company focused on addressing drug and vaccine losses in the cold chain logistics sector. Their flagship product, the Ember Cube 2, is a reusable, modular shipping solution that offers real-time monitoring and cloud-based tracking, targeting costly temperature excursions in pharmaceutical logistics.

Waypoint Bio is a biotechnology company focused on developing innovative CAR-T therapies. The company aims to address unmet medical needs in cancer treatment through its clinical trials in China. This funding will support the execution of three CAR-T trials, highlighting the company's commitment to advancing cancer therapies.

Oli is a medtech startup that has developed a wearable device for maternal and fetal monitoring, aimed at predicting and reducing birth complications. The company focuses on improving health outcomes for mothers and babies through advanced technology that captures physiological data during labor.

Mia Healthcare Technologies is a South African e-health startup that focuses on expanding access to affordable dental care. The company offers high-quality, locally-produced clear aligners through a network of mobile and fixed dental practices, addressing issues of cost and accessibility in the dental market.

Lucis is a French preventive health platform that focuses on improving health outcomes through proactive measures. The company targets consumers looking for innovative health solutions. This funding round will help Lucis expand its offerings and reach more users.

ANDHealth is a company focused on advancing digital health solutions. They provide support for the development and commercialization of digital health technologies, targeting healthcare providers and patients. The recent funding round of AUD $9 million highlights the growing demand for innovative health solutions amidst a capital squeeze in the industry.

Mia Healthcare is a South African e-health startup that provides affordable dental care through a network of mobile and fixed dental practices. The company offers high-quality, locally-produced clear aligners at accessible price points, aiming to improve access to dental and orthodontic care across Southern Africa.

Sound Wave is a Japanese startup focused on developing solutions for Alzheimer's disease. The company aims to innovate in the healthcare sector by leveraging technology to improve the lives of those affected by this condition. The recent funding round will help accelerate their research and development efforts.

Neuralink is a neurotechnology company that develops implantable brain–machine interfaces. The company aims to enable direct communication between the brain and computers, which could have applications in treating neurological conditions and enhancing human capabilities.

Mave Health is a healthtech startup that develops non-invasive wearable headsets aimed at improving focus, mood, and stress regulation. The company targets consumers in the US and India, offering a device that uses low-intensity electrical signals to stimulate the brain and enhance mental health. This funding round will help launch their product and expand manufacturing capabilities.

CVRD Health is a Miami-based startup that specializes in streamlining health and welfare benefits for federal contractors. The company aims to modernize the sector by providing a platform that offers real-time visibility into benefit obligations and spending, addressing inefficiencies in traditional health plans.

Gabit is a wearable healthtech startup that focuses on fitness, nutrition, sleep, and stress management. The company offers smart wearables, including a titanium smart ring that tracks over 150 health markers, alongside AI-powered coaching and personalized nutrition and skincare products. Founded by former Zomato and SkillTap executives, Gabit aims to integrate wellness solutions in a rapidly growing market.